SCHEMBL13625464

SCHEMBL13625464

NCCCCC(NC(=O)CCS)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.59
SLC6A5 Q9Y345 1/20 0.57
GNPAT O15228 1/20 0.51
NOD1 Q9Y239 4/20 0.46
CPB2 Q96IY4 2/20 0.46
RNPEP Q9H4A4 1/20 0.46
SLC15A2 Q16348 1/20 0.43
GSR P00390 1/20 0.43
NMT2 O60551 1/20 0.41
NMT1 P30419 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
FNTA P49354 2/20 0.40
FNTB P49356 2/20 0.40
PGGT1B P53609 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27739688 1.00 FOLH1 (0.59) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL13625463 0.95 FOLH1 (0.53) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL232587 0.88 SLC6A5 (0.65) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL482959 0.88 FOLH1 (0.65) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL4272196 0.88 FOLH1 (0.65) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL232527 0.88 SLC6A5 (0.65) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL13625380 0.88 GNPAT (0.47) FOLH1SLC6A5GNPATNOD1FNTA
SCHEMBL18104611 0.87 HPGDS (0.44) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL1681307 0.86 FOLH1 (0.58) FOLH1SLC6A5GNPATNOD1CPB2
SCHEMBL7027662 0.86 SLC6A5 (0.72) FOLH1SLC6A5GNPATNOD1GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937048-B2 Anti-angiogenic compounds COVX TECHNOLOGIES IRELAND, LIMITED (IE) 2015-01-20 US disclosed
WO-2009136352-A1 ANTI-ANGIOGENIC COMPOUNDS COVX TECHNOLOGIES IRELAND, LTD. (IE) 2009-11-12 WO disclosed
CN-101296708-A Selective VPAC2 receptor peptide agonists LILLY CO ELI (US) 2008-10-29 CN disclosed